Intrepid transcatheter mitral valve replacement system on dark blue background

NOW ENROLLING THE APOLLO TRIAL


Learn more about the trial evaluating the Intrepid™ Transcatheter Mitral Valve Replacement System — an investigational option for patients with moderate to severe symptomatic mitral regurgitation (MR), with or without mitral annular calcification (MAC), who meet eligibility criteria for the APOLLO Trial.
LEARN ABOUT APOLLO

CAUTION: The Intrepid™ Transcatheter Mitral Valve Replacement System is an investigational device. Limited by federal (United States) law to investigational use. Exclusively for clinical investigations. Not approved by FDA and not for sale in the United States.

LEARN ABOUT THE TRIAL
Explore Eligibility Criteria
SEE TRIAL LOCATIONS